Hodgkin Disease: all 914 studies
Page 8 of 10. Open to participants first (136), then studies with results posted, then the rest; newest registration first within each.
- MSC and HSC Coinfusion in Mismatched MinitransplantsTerminatedNCT01045382Phase 2
- Resminostat (4SC-201) in Relapsed or Refractory Hodgkin's LymphomaCompletedNCT01037478Phase 2
- Clinical Pharmacology Study of Brentuximab Vedotin (SGN-35)CompletedNCT01026415Phase 1
- Cardiac Safety Study of Brentuximab Vedotin (SGN-35)CompletedNCT01026233Phase 1
- Valproic Acid in Treating Patients With Previously Treated Non-Hodgkin Lymphoma, Hodgkin Lymphoma, or Chronic Lymphocytic LeukemiaStatus unknownNCT01016990Phase 2
- Protection of Ovarian Function in Female Patients With Hodgkin LymphomaCompletedNCT01014507Phase 2
- Gonadal Toxicity in Women With Hodgkin LymphomaStatus unknownNCT01008735
- R-ABVD vs ABVD-RT in Early Stage Hodgkin's LymphomaTerminatedNCT00992030Phase 3
- Safety Study Looking at the Use of a Natural Killer Cell Line Against Hematological MalignanciesCompletedNCT00990717Phase 1
- Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic MalignancyCompletedNCT00990587Phase 1
- 124I-FIAU Imaging in EBV and KSHV Associated CancersCompletedNCT00982449Not applicable
- Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood DisordersTerminatedNCT00973804Phase 1
- Immune Mobilization of Autologous Peripheral Blood Stem Cells Using Interleukin-2 and GM-CSFCompletedNCT00952237Phase 1
- Host Dendritic Cells in Allograft PatientsStatus unknownNCT00935597Phase 1
- 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With CancerActive, not recruitingNCT00935090
- Evaluation of Late Treatment Effects in Long-Term Survivors of Hodgkin's Disease Previously Treated at NIH: A Multi-Institutional TrialCompletedNCT00924131
- Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin LymphomaTerminatedNCT00920153Phase 3
- Pilot Study of Unrelated Cord Blood TransplantationTerminatedNCT00916045Phase 2
- Intentional Rejection of the Donor Graft Using Recipient Leukocyte Infusion(s) Following Nonmyeloablative Allogeneic Stem Cell TransplantTerminatedNCT00909948Phase 1
- Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin LymphomaStatus unknownNCT00908180Phase 2
- Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin LymphomaStatus unknownNCT00907036Phase 2
- Cardiac Effects in Long-Term Survivors of Hodgkin's and Non-Hodgkin's LymphomaCompletedNCT00903890
- Azacitidine With Rituximab, Vincristine, and Cyclophosphamide in Refractory LymphomaCompletedNCT00901069Phase 1
- Collecting and Storing Biological Samples From Young Patients With Hodgkin?s LymphomaCompletedNCT00900250
- Studying Fentanyl in Patients With CancerTerminatedNCT00899951
- Umbilical Cord Blood Transplant for Hematological MalignanciesCompletedNCT00891592Phase 1
- Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral TherapyCompletedNCT00890747Phase 1
- Positron Emission Tomography(PET) in Lymphoma AssessmentCompletedNCT00887718Not applicable
- Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to TreatmentWithdrawnNCT00881387Phase 2
- Consolidation PET-based and Donor-based After Salvage Therapy in Patients With HL in Relapse or RefractoryTerminatedNCT00879528
- Early Chemotherapy Intensification in Interim-Positron Emission Tomography (PET) Positive Hodgkin LymphomaStatus unknownNCT00877747
- Infusion of Genetically Modified T Cell for Post Transplant Patients With Relapsed DiseaseCompletedNCT00871702Phase 1
- Methionine PET/CT Studies In Patients With CancerActive, not recruitingNCT00840047Phase 2
- Temsirolimus for Relapsed/Refractory Hodgkin's LymphomaTerminatedNCT00838955Phase 2
- A Multi-centre, Open Label, Single-arm Study Intended to Further Investigate the Safety and Efficacy of Plerixafor as a Front-line Mobilisation Agent in Combination With G-CSF in Patients With Lymphoma or MM (Multiple Myeloma).CompletedNCT00838357Phase 3
- Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's LymphomaStatus unknownNCT00816959Phase 3
- Internet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsCompletedNCT00799461Phase 3
- Study Comparing R-mabHD and a Combination of ABVD in Hodgkin's DiseaseStatus unknownNCT00797472Phase 2
- Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)Status unknownNCT00795613Phase 2
- High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative PatientsCompletedNCT00784537Phase 2/3
- FAU in Treating Patients With Advanced Solid Tumors or LymphomaCompletedNCT00769288Phase 1
- Blood Samples to Evaluate Biomarkers of Donor ChimerismCompletedNCT00764829
- A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With CancerCompletedNCT00754286Not applicable
- A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid MalignanciesCompletedNCT00741871Phase 1
- HD16 for Early Stage Hodgkin LymphomaStatus unknownNCT00736320Phase 3
- This is a Multi-center, Single Arm, Open Label Study Intended to Provide Expanded Access to Plerixafor for Patients With Non-Hodgkin's Lymphoma (NHL), Hodgkin's Disease (HD) or Multiple Myeloma (MM) Who Are to Receive Treatment With an Autologous Peripheral Stem Cell Transplant.No longer availableNCT00720603
- Irinotecan, Vincristine, and Dexamethasone In Children With Relapsed And/Or Refractory Hematologic MalignanciesCompletedNCT00718757Phase 1
- Health and Psychosocial Outcomes in Long-Term Lymphoma SurvivorsCompletedNCT00713882
- Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell TransplantCompletedNCT00697684Phase 1
- Whole-body Magnetic Resonance Imaging (MRI) for Staging Malignant LymphomasCompletedNCT00685997
- Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin LymphomaCompletedNCT00678327Phase 3
- Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell TransplantTerminatedNCT00674427Phase 1
- Study of HCD122 in Adults With Non-Hodgkin's or Hodgkin's Lymphoma Who Have Progressed After at Least Two Prior TherapiesCompletedNCT00670592Phase 1/2
- Combination Chemotherapy in Treating Younger Patients With Hodgkin LymphomaCompletedNCT00666484Phase 2
- Evaluation of the Safety and Efficacy of the Addition of AMD3100 to a G-CSF Mobilization Regimen in Patients With Lymphoma (NHL and HD) and Multiple Myeloma (MM).CompletedNCT00665314Phase 2
- A Phase I Dose Escalation Study of SGN-35 Alone and in Combination With Gemcitabine for CD30-Positive MalignanciesTerminatedNCT00649584Phase 1
- Carmustine, Etoposide, Cyclophosphamide, and Stem Cell Transplant in Treating Patients With HIV-Associated LymphomaCompletedNCT00641381Phase 1
- Nonmyeloablative Allo SCT for the Treatment of Hematologic DisordersCompletedNCT00636909Phase 2
- A Phase II Study of IGEV +/- Bortezomib Before Hign Dose Consolidation in Relapsed/Refractory Hodgkin's LymphomaCompletedNCT00636311Phase 2
- Phase 1 Study of MDX-1401 in Patients With CD30-positive Refractory/Relapsed Hodgkin's LymphomaCompletedNCT00634452Phase 1
- Prevalence+Significance of Paraneoplastic Autoantibodies in Many CancersCompletedNCT00608452
- Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryCompletedNCT00608361Phase 1
- Safety Study of XmAb®2513 to Treat Hodgkin Lymphoma or Anaplastic Large Cell LymphomaCompletedNCT00606645Phase 1
- Total Body Irradiation With Fludarabine Followed by Combined Umbilical Cord Blood (UCB) TransplantsCompletedNCT00606437Phase 1
- Quality of Life Among Survivors of Hodgkin LymphomaCompletedNCT00598728
- A Comprehensive Study of Clinically Staged Pediatric Hodgkin's Disease: Chemotherapy for All Patients; Supplementary Low Dose Involved Field Irradiation for Selected Patients (CCG 5942)CompletedNCT00592111Phase 2
- Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)CompletedNCT00587873Phase 2
- Spectroscopy With Surface Coils and DecouplingCompletedNCT00581815Phase 1
- Behavioral Intervention For BMT/SCT SurvivorsCompletedNCT00579917
- Palifermin After Haploidentical PBSCTWithdrawnNCT00570999Phase 2
- Investigation of the Cylex® ImmuKnow® AssayCompletedNCT00569842
- Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer PatientsCompletedNCT00562224Phase 1
- Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old ChildrenCompletedNCT00552825
- Prediction of the Response to Chemotherapy by Tomoscintigraphie the MIBI in the Balance Sheet Pre Hodgkin's Disease and Lymphoma Malins High GradeCompletedNCT00551798Not applicable
- Prospective Data Collection of Newly Diagnosed Hodgkin's Disease and Non-Hodgkin's Lymphoma CasesStatus unknownNCT00538551
- Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCTCompletedNCT00534989Not applicable
- Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's DiseaseCompletedNCT00534820Not applicable
- Nonmyeloablative Allogeneic Stem Cell Transplantation From HLA-Matched Unrelated Donor for the Treatment of Hematologic DisordersCompletedNCT00533923Phase 2
- HD18 for Advanced Stages in Hodgkins LymphomaCompletedNCT00515554Phase 3
- Pilot Study of Umbilical Cord Blood Transplantation in Adult Patient With Advanced Hematopoietic MalignanciesTerminatedNCT00514722Not applicable
- PVAG-14 Pilot for Intermediate Stages Hodgkin LymphomaTerminatedNCT00512980Phase 2
- Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell TransplantCompletedNCT00510315
- Vorinostat in Treating Patients With Metastatic or Unresectable Solid Tumors or Lymphoma and Liver DysfunctionCompletedNCT00499811Phase 1
- phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma PatientsTerminatedNCT00496431Phase 1/2
- Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerCompletedNCT00489203Phase 2
- Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00478959Phase 2
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative TherapyCompletedNCT00469729Phase 2/3
- Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological MalignanciesCompletedNCT00460694Phase 1/2
- Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
- Treatment of Advanced Hodgkin's Disease (Stages IIB-III-IV)CompletedNCT00443677Phase 3
- Safety and Efficacy Study of TNX-650 to Treat Refractory Hodgkin's LymphomaStatus unknownNCT00441818Phase 1/2
- Velcade Plus ICE for Patients With Relapsed Classical Hodgkin LymphomaCompletedNCT00439361Phase 1
- Combination Chemotherapy in Treating Young Patients With Hodgkin's LymphomaCompletedNCT00433459Phase 3
- Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's LymphomaStatus unknownNCT00433433Phase 3
- Phase I Open-Label Dose Finding Study of SGN-35 for CD30 Positive Hematologic MalignanciesCompletedNCT00430846Phase 1
- Endothelial Function and IMT in Survivors of Hodgkin's LymphomaCompletedNCT00428688
- Allogeneic Blood Stem Cell TransplantationCompletedNCT00423709Not applicable
- Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Hodgkin's LymphomaCompletedNCT00416832Phase 2
- Combination Chemotherapy in Treating Young Male Patients With Hodgkin's LymphomaCompletedNCT00398554Phase 2
- Tailored Therapy for Hodgkin Lymphoma Using Early Interim Therapy PET for Therapy Decision.CompletedNCT00392314Phase 2